Search - tctmd.com

Displaying 21 - 40 of 80

Sort: Relevancy | Date

News Daily News

In MITRA-FR, ‘Disproportionate’ MR Theory Doesn’t Pan Out

Shelley Wood

September 18, 2020

News Conference News TVT 2020

Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years

Michael O'Riordan

June 22, 2020

News Conference News TVT 2020

MitraClip Cuts Death, HF Hospitalization Across NYHA Class: COAPT

Michael O'Riordan

June 21, 2020

News Daily News ACC 2020

Better QoL After MitraClip Plus Fewer Deaths, HF Hospitalizations: COAPT

Shelley Wood

March 17, 2020

News Daily News

PARTNER 2A at EACTS 2019: ‘The Message Is Exactly the Same’

Shelley Wood

October 08, 2019

Presentation TCT 2019

Transcatheter Mitral Valve Repair and Replacement Clinical Trial Designs After COAPT and MITRA-FR

Presenter: Gregg Stone

September 28, 2019

News Conference News TCT 2019

COAPT at 3 Years: Crossover Patients See Benefits From MitraClip

Shelley Wood

September 28, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Three: Thowback Saturday Revisits COAPT, PARTNER 2A, and EXCEL

Shelley Wood

September 28, 2019

Presentation TCT 2019

Pivotal Transcatheter FMR Device Trials: Future Perspectives One Year After COAPT and MITRA-FR

Presenter: Gregg Stone

September 27, 2019

News Conference News ESC 2019

MITRA-FR at 2 Years: Still No Benefit of MitraClip Over Meds

Shelley Wood

September 02, 2019

News Daily News

Better Outcomes, Fewer Complications Among Higher-Volume MitraClip Sites

Michael O'Riordan

July 17, 2019

News Conference News TVT 2019

Pascal Transcatheter Device Safe, Improves Tricuspid Regurgitation: Early Results

Shelley Wood

June 19, 2019

Presentation TVT 2019

TMVR Pivotal Trial Designs in the COAPT Era

Presenter: Gregg Stone

June 14, 2019

Presentation TVT 2019

COAPT: Perspectives on Clinical Trial Data and Anticipated US Patient Selection Criteria for FMR

Presenter: Gregg Stone

June 14, 2019

Presentation TVT 2019

A Synthesis of COAPT, MitraFR, and Other FMR Trials: Clinical Implications

Presenter: Gregg Stone

June 13, 2019

Presentation TVT 2019

V-Wave

Presenter: Gregg Stone

June 12, 2019

News Daily News

Proportionate and Disproportionate MR: A ‘Framework’ for MitraClip and Medical Therapy

Shelley Wood

May 09, 2019

News Daily News

FDA Extends MitraClip Indication to Include Functional MR

Shelley Wood

March 14, 2019

Presentation JIM 2019

Treatment of Mitral Regurgitation in Heart Failure COAPT and beyond

Presenter: Gregg W. Stone

February 14, 2019

Podcast TCTMD Talking Points

COAPT: A Randomized Trial of Transcatheter Mitral Valve Leaflet Approximation in Patients With Heart Failure and Secondary Mitral Regurgitation

December 12, 2018

Advertisement

In MITRA-FR, ‘Disproportionate’ MR Theory Doesn’t Pan Out

Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years

MitraClip Cuts Death, HF Hospitalization Across NYHA Class: COAPT

Better QoL After MitraClip Plus Fewer Deaths, HF Hospitalizations: COAPT

PARTNER 2A at EACTS 2019: ‘The Message Is Exactly the Same’

Transcatheter Mitral Valve Repair and Replacement Clinical Trial Designs After COAPT and MITRA-FR

COAPT at 3 Years: Crossover Patients See Benefits From MitraClip

TCT 2019 Day Three: Thowback Saturday Revisits COAPT, PARTNER 2A, and EXCEL

Pivotal Transcatheter FMR Device Trials: Future Perspectives One Year After COAPT and MITRA-FR

MITRA-FR at 2 Years: Still No Benefit of MitraClip Over Meds

Better Outcomes, Fewer Complications Among Higher-Volume MitraClip Sites

Pascal Transcatheter Device Safe, Improves Tricuspid Regurgitation: Early Results

TMVR Pivotal Trial Designs in the COAPT Era

COAPT: Perspectives on Clinical Trial Data and Anticipated US Patient Selection Criteria for FMR

A Synthesis of COAPT, MitraFR, and Other FMR Trials: Clinical Implications

V-Wave

Proportionate and Disproportionate MR: A ‘Framework’ for MitraClip and Medical Therapy

FDA Extends MitraClip Indication to Include Functional MR

Treatment of Mitral Regurgitation in Heart Failure COAPT and beyond

COAPT: A Randomized Trial of Transcatheter Mitral Valve Leaflet Approximation in Patients With Heart Failure and Secondary Mitral Regurgitation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content